Skip to main content

Find Clinical Trials

Home
Conditions
Meningeal Hemangiopericytoma

Clinical trial condition

Meningeal Hemangiopericytoma

Explore clinical trials studying Meningeal Hemangiopericytoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Meningeal Hemangiopericytoma trial results

Completed

Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2

NCT01082926

Conditions: Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Meningioma, +33 more
Locations: City of Hope Duarte, California, United States

View Trial Details